-
Fact Sheet
The Silver Book: Atrial Fibrillation
Atrial fibrillation impacts between 2.7 and 6.1 million adults and can lead to stroke, heart failure, dementia, disability, and death. It also costs a tremendous amount of money--at least $6.65 billion each year. This latest factsheet from The Silver Book brings the leading data on the burden of the disease and the value of innovation to reduce that burden, all into one place.
-
Press Release
Statement on FDA Draft Guidance for Alzheimer’s Drug Development
-
Document, Feature Article
Translating Innovation to Impact
This white paper presents the findings and recommendations from a review of the state of the art non-pharmacological treatments and care practices for people with Alzheimer's or other dementias and their family caregivers. It is intended to support deliberations by the Advisory Council on Alzheimer's Research, Care and Services, the U.S. Department of Health & Human Services (HHS) and other government and private organizations about hot to make effective non-pharmacological treatments and care practices available to people who will benefit from then. Its development resulted from a public-private partnership between AoA and the Alliance for Aging Research, with funding from the Metlife Foundation.
-
Press Release
Teleconference explains ways to reduce Medicare costs
Kenneth E. Thorpe, PhD, professor of Health Policy and Management at Emory’s Rollins School of Public Health along with colleague Daniel Perry, president and CEO of the Alliance for Aging Research, suggest adopting specific initiatives such as transitional and team-based care, comprehensive medication therapy management, and health coaching to slow the growth in spending and improve quality of care. The team will host a teleconference on Thursday, December 13 from 10:30 a.m. – 11 a.m. to discuss these recommendations.
-
Document
Assessing Stroke and Bleeding Risk in Atrial Fibrillation
This expert consensus statement makes important recommendations on the use of stroke and bleeding risk tools, the decision to anticoagulate, the incorporation of patient preferences, and more.
